Stalter G, Siemer S, Becht E, Ziegler M, Remberger K, Issinger O G
Urologische Klinik, Universität des Saarlandes, Homburg/Saar, Germany.
Biochem Biophys Res Commun. 1994 Jul 15;202(1):141-7. doi: 10.1006/bbrc.1994.1904.
Renal clear cell carcinomas and the corresponding ipsilateral control tissues were investigated for protein kinase CK2 activity and subunit ratio. The average protein kinase CK2 activity from 21 different kidney samples was 318 U/mg and that from the corresponding tumors 610 U/mg. The subunit ratio of protein kinase CK2 alpha in tumors/normal tissue (T/N) was 1.58 and that of the protein kinase CK2 beta (T/N) was 2.65. The data suggest that the generally described increase in protein kinase CK2 activity in tumor cells may to some extent result from a deregulation in subunit biosynthesis or degradation. This at least partly owing to the presence of excess enzymatically active protein kinase alpha-subunit but also to a significantly higher presence of the non-catalytic beta-subunit.
对肾透明细胞癌及相应的同侧对照组织进行蛋白激酶CK2活性和亚基比率研究。来自21个不同肾脏样本的蛋白激酶CK2平均活性为318 U/mg,相应肿瘤的平均活性为610 U/mg。肿瘤/正常组织(T/N)中蛋白激酶CK2α的亚基比率为1.58,蛋白激酶CK2β的亚基比率(T/N)为2.65。数据表明,通常所描述的肿瘤细胞中蛋白激酶CK2活性增加,可能在一定程度上是由于亚基生物合成或降解失调所致。这至少部分归因于存在过量的具有酶活性的蛋白激酶α亚基,但也归因于非催化性β亚基的显著更高含量。